Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties (original) (raw)

Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals

J. Contrera

Regulatory Toxicology …, 1997

View PDFchevron_right

Prediction of 2-Year Carcinogenicity Study Results for Pharmaceutical Products: How Are We Doing?

abby jacobs

Toxicological Sciences, 2005

View PDFchevron_right

Third Chronological Supplement to the Carcinogenic Potency Database: Standardized Results of Animal Bioassays

Thomas Slone

2013

View PDFchevron_right

Which drugs cause cancer? * Cancer bioassays

Andrew Knight

BMJ, 2005

View PDFchevron_right

Key characteristics of 86 agents known to cause cancer in humans

Mustafa Al-Zoughool

Journal of Toxicology and Environmental Health, Part B, 2019

View PDFchevron_right

Supplement to the Carcinogenic Potency Database (CPDB): Results of Animal Bioassays Published in the General Literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996

Neela Manley

Environmental Health Perspectives, 1999

View PDFchevron_right

The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program

Neela Manley

Environmental Health Perspectives, 1991

View PDFchevron_right

Target Organs in Chronic Bioassays of 533 Chemical Carcinogens

Leslie Bernstein

Environmental Health Perspectives, 1991

View PDFchevron_right

Carcinogenicity Testing of Pharmaceuticals in the European Union: A Workshop Report

Beatriz Silva Lima

Drug Information Journal, 2000

View PDFchevron_right

Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug development

abby jacobs

Toxicological sciences : an official journal of the Society of Toxicology, 2004

View PDFchevron_right

The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989

Neela Manley

Environmental Health Perspectives, 1993

View PDFchevron_right

Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987

Thomas Slone

Environmental Health Perspectives, 1990

View PDFchevron_right

Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986

Peggy A. Lopipero-Langmo

Environmental Health Perspectives, 1987

View PDFchevron_right

Carcinogenicity of Biopharmaceuticals

Jan Willem van der Laan

Genotoxicity and Carcinogenicity Testing of Pharmaceuticals, 2015

View PDFchevron_right

Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals--scientific perspective

Jan Willem van der Laan

Toxicology letters, 2000

View PDFchevron_right

Preclinical toxicology of anticancer agents

Philip Schein

Cancer research, 1977

View PDFchevron_right

Association between Carcinogenic Potency and Tumor Pathology in Rodent Carcinogenesis Bioassays

Leslie Bernstein

Toxicological Sciences, 1986

View PDFchevron_right

Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays*1

Bonnie R Stern, PhD, MPH

Fundamental and Applied Toxicology, 1986

View PDFchevron_right

Compendium of Chemical Carcinogens by Target Organ: Results of Chronic Bioassays in Rats, Mice, Hamsters, Dogs, and Monkeys

Thomas Slone

Toxicologic Pathology, 2001

View PDFchevron_right

Quantitative Correlation with Carcinogenic Potency of Different Short Term Tests

Leonardo Santi

Toxicologic Pathology, 1984

View PDFchevron_right

Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals: A Review of Approved Molecules and Best Practice Recommendations

R. Steigerwalt

Toxicologic Pathology, 2010

View PDFchevron_right

Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans

Yann Grosse

Journal of Toxicology and Environmental Health, Part B, 2019

View PDFchevron_right

Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program

Cynthia Van Landingham

Environmental Health Perspectives, 1999

View PDFchevron_right

Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993

Bonnie R Stern, PhD, MPH, Neela Manley, Thomas Slone

Environmental Health Perspectives, 1995

View PDFchevron_right

A Retrospective Evaluation of COMPACT Predictions of the Outcome of NTP Rodent Carcinogenicity Testing

Costas Ioannides

Environmental Health Perspectives, 1995

View PDFchevron_right

Veterinary Drugs No Longer Need Testing for Carcinogenicity in Rodent Bioassays

D. Galer

Regulatory Toxicology and Pharmacology, 1998

View PDFchevron_right

How accurate is in vitro prediction of carcinogenicity?

Nicholas Billinton, Richard Walmsley

British Journal of Pharmacology, 2011

View PDFchevron_right

Regulatory requirements and ICH guidelines on carcinogenicity testing of pharmaceuticals: A review on current status

Gopabandhu Jena

Indian Journal of Pharmacology, 2005

View PDFchevron_right

New clues on carcinogenicity.pdf

Giuseppina C Gini, Alessandra Roncaglioni

View PDFchevron_right

The in Vivo Rodent Test Systems for Assessment of Carcinogenic Potential

Jan-Willem van der Laan

Regulatory Toxicology and Pharmacology, 2002

View PDFchevron_right